1. Home
  2. HDSN vs LRMR Comparison

HDSN vs LRMR Comparison

Compare HDSN & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

HOLD

Current Price

$7.31

Market Cap

409.2M

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.70

Market Cap

332.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDSN
LRMR
Founded
1991
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.2M
332.1M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
HDSN
LRMR
Price
$7.31
$3.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$9.50
$16.71
AVG Volume (30 Days)
524.0K
1.5M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.50
N/A
Revenue
$236,847,000.00
N/A
Revenue This Year
$2.65
N/A
Revenue Next Year
$3.69
N/A
P/E Ratio
$14.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.11
$1.61
52 Week High
$10.52
$6.91

Technical Indicators

Market Signals
Indicator
HDSN
LRMR
Relative Strength Index (RSI) 46.12 51.60
Support Level $6.53 $3.12
Resistance Level $7.74 $3.69
Average True Range (ATR) 0.27 0.27
MACD 0.17 0.04
Stochastic Oscillator 63.64 84.56

Price Performance

Historical Comparison
HDSN
LRMR

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: